| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871481 | The Annals of Thoracic Surgery | 2016 | 7 Pages |
Abstract
MIE proves its safety after neoadjuvant therapy because it leads to faster progression during the early postoperative period while reducing pulmonary complications. Open and MIE approaches appear equivalent with regards to perioperative oncologic outcomes after neoadjuvant therapy. Long-term outcomes need further validation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Luis F. MD, Douglas J. MD, Cameron D. MD, John C. MD, Henning A. MD, Ashok MD, Michael MD, Dean M. MD, Christopher R. MD,